Open AccessVancomycin resistant Staphylococcus aureus in the United States
Author(s) -
Neil Woodford
Publication year - 2002
Language(s) - English
Resource type - Journals
ISSN - 9999-1233
DOI - 10.2807/esw.06.28.01913-en
Subject(s) - teicoplanin , glycopeptide , vancomycin , microbiology and biotechnology , staphylococcus aureus , enterococcus faecalis , medicine , enterococcus faecium , enterococcus , methicillin resistant staphylococcus aureus , coagulase , staphylococcus , biology , antibiotics , bacteria , genetics
Since the first reports of glycopeptide resistant enterococci (GRE) in 1987, concern has been expressed about enterococcal van genes, which encode vancomycin resistance, reaching Staphylococcus aureus. This often voiced fear has now been realised, with the reported isolation of a VanA MRSA (vancomycin minimum inhibitory concentration (MIC) >128 mg/L; teicoplanin MIC 32 mg/L) from the tip of a dialysis catheter and from a chronic foot ulcer of a patient in Michigan, in the United States; glycopeptide resistant Enterococcus faecalis (genotype not specified) was also isolated from the ulcer (1).